Keywords: واکسن مارکر; C-DIVA; China strain derived marker vaccine; CSF; Classical swine fever; DIVA; Differentiation between Infected and Vaccinated Animals; TAGSÎÎTLR; modified TAVSPTTLR epitope in C-DIVA; TAVSPTTLR; epitope of CSF E2; Classical swine fever; Marker vaccine;
مقالات ISI واکسن مارکر (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: واکسن مارکر; Water buffalo; BuHV-1; BoHV-1; Marker vaccine;
Keywords: واکسن مارکر; Classical swine fever; Marker vaccine; Maternally derived antibodies; Passive protection
Protection against transplacental transmission of moderately virulent classical swine fever virus using live marker vaccine “CP7_E2alf”
Keywords: واکسن مارکر; Classical swine fever; Marker vaccine; Efficacy; Transplacental transmission; Differentiating infected from vaccinated animals;
A high-temperature passaging attenuated Pseudorabies vaccine protects piglets completely against emerging PRV variant
Keywords: واکسن مارکر; Pseudorabies virus; High-temperature passaging; Marker vaccine;
Pre-registration efficacy study of a novel marker vaccine against classical swine fever on maternally derived antibody positive (MDA+) target animals
Keywords: واکسن مارکر; Classical swine fever; CSFV; Marker vaccine; MDA+; European pharmacopoeia; DIVA;
Vaccines against pseudorabies virus (PrV)
Keywords: واکسن مارکر; Suid herpesvirus 1; Aujeszky's disease virus; Pseudorabies virus; Marker vaccine; Recombinant vaccine;
Kinetics of maternally derived antibodies upon intramuscular vaccination against classical swine fever with Suvaxyn® CSF Marker (CP7_E2alf)
Keywords: واکسن مارکر; Classical swine fever; Marker vaccine; CP7_E2alf; Maternally derived antibodies; Kinetics;
Efficacy of the marker vaccine rAdV-SFV-E2 against classical swine fever in the presence of maternally derived antibodies to rAdV-SFV-E2 or C-strain
Keywords: واکسن مارکر; Classical swine fever; Marker vaccine; Maternally derived antibodies; Efficacy; Interference;
Efficacy of Suvaxyn CSF Marker (CP7_E2alf) in the presence of pre-existing antibodies against Bovine viral diarrhea virus type 1
Keywords: واکسن مارکر; Classical swine fever; Marker vaccine; CP7_E2alf; Efficacy; BVDV antibodies; DIVA diagnostics;
Growth properties and vaccine efficacy of recombinant pseudorabies virus defective in glycoprotein E and thymidine kinase genes
Keywords: واکسن مارکر; Pseudorabies virus; Marker vaccine; Recombinant virus; Live attenuated virus
The rescue and evaluation of FLAG and HIS epitope-tagged Asia 1 type foot-and-mouth disease viruses
Keywords: واکسن مارکر; Foot-and-mouth disease virus (FMDV); Reverse genetic; Recombinant; Marker vaccine
A live, attenuated pseudorabies virus strain JS-2012 deleted for gE/gI protects against both classical and emerging strains
Keywords: واکسن مارکر; Pseudorabies virus; gE/gI deletion; Marker vaccine;
Classical swine fever virus marker vaccine strain CP7_E2alf: Shedding and dissemination studies in boars
Keywords: واکسن مارکر; Classical swine fever; Marker vaccine; CP7_E2alf; Dissemination; Shedding; Boar
Novel pseudorabies virus variant with defects in TK, gE and gI protects growing pigs against lethal challenge
Keywords: واکسن مارکر; PRV variant; Marker vaccine; Growing pigs; Safety; Efficacy;
Development of an improved live attenuated antigenic marker CSF vaccine strain candidate with an increased genetic stability
Keywords: واکسن مارکر; Marker vaccine; DIVA strategy; Protection; Minimal protective dose; Vaccine safety; Classical swine fever virus;
Two newly developed Erns-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies
Keywords: واکسن مارکر; Classical Swine Fever virus; Pestivirus; DIVA; CP7_E2alf; Discriminatory ELISA; Marker vaccine
A novel dendrimeric peptide induces high level neutralizing antibodies against classical swine fever virus in rabbits
Keywords: واکسن مارکر; Classical swine fever virus; Dendrimeric peptide; Neutralizing epitope; T helper cell epitope; Marker vaccine
Stable expression of foreign gene in nonessential region of nonstructural protein 2 (nsp2) of porcine reproductive and respiratory syndrome virus: Applications for marker vaccine design
Keywords: واکسن مارکر; PRRSV; nsp2; Stable expression; Marker vaccine
Foot-and-mouth disease marker vaccine: Cattle protection with a partial VP1 G-H loop deleted virus antigen
Keywords: واکسن مارکر; Foot-and-mouth disease; VP1 G-H loop; Marker vaccine;
Protective efficacy of a Classical swine fever virus C-strain deletion mutant and ability to differentiate infected from vaccinated animals
Keywords: واکسن مارکر; Classical swine fever virus; C-strain; DIVA; Marker vaccine;
Characterization of a new chimeric marker vaccine candidate with a mutated antigenic E2-epitope
Keywords: واکسن مارکر; Pestivirus; Classical swine fever; Marker vaccine; DIVA; Chimeric construct
Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion
Keywords: واکسن مارکر; Foot-and-mouth disease; VP1 G-H loop; Marker vaccine
H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens
Keywords: واکسن مارکر; Avian influenza; H5N1; Marker vaccine
Preliminary Evaluation of a Candidate Multi-Epitope-Vaccine Against the Classical Swine Fever Virus
Keywords: واکسن مارکر; classical swine fever virus (CSFV); marker vaccine; multi-epitope-vaccine; synergic effect;
Cedivac-FMD can be used according to a marker vaccine principle
Keywords: واکسن مارکر; FMD; Marker vaccine; Emergency vaccination; Non-structural proteins
Compatibility of a live infectious bovine rhinotraheitis (IBR) marker vaccine and an inactivated bovine viral diarrhoea virus (BVDV) vaccine
Keywords: واکسن مارکر; Pestivirus; Herpesvirus; Cattle; Marker vaccine; Compatibility
A Semliki Forest virus replicon vectored DNA vaccine expressing the E2 glycoprotein of classical swine fever virus protects pigs from lethal challenge
Keywords: واکسن مارکر; Classical swine fever virus; Alphavirus replicon vector; DNA vaccine; Marker vaccine
The threat of peste des petits ruminants: progress in vaccine development for disease control
Keywords: واکسن مارکر; Peste des petits ruminants (PPR); Morbillivirus; Marker vaccine; Reverse genetics; Poxvirus recombinant vaccines
Marker vaccine strategies and candidate CSFV marker vaccines
Keywords: واکسن مارکر; Classical swine fever (CSF); Marker vaccine; Diagnostic test
Fusion Proteins Cpn10-Erns with Properties of Generating CSFV-Neutralized Antibodies1
Keywords: واکسن مارکر; Classical swine fever virus; Erns; Chaperonin; Marker vaccine;
Spying the neutralizing epitopes on E2 N-terminal by candidate epitope-vaccines against classical swine fever virus
Keywords: واکسن مارکر; Classical swine fever virus (CSFV); Sequential neutralizing epitope; Epitope-vaccine; Marker vaccine
Candidate peptide-vaccines induced immunity against CSFV and identified sequential neutralizing determinants in antigenic domain A of glycoprotein E2
Keywords: واکسن مارکر; Classical swine fever virus (CSFV); Sequential neutralizing epitope; Peptide-vaccine (PV); Multi-peptide-vaccine (MPV); Marker vaccine
Candidate peptide-vaccine induced potent protection against CSFV and identified a principal sequential neutralizing determinant on E2
Keywords: واکسن مارکر; Classical swine fever virus (CSFV); Marker vaccine; Peptide vaccine; Sequential neutralizing epitope; Immunodominant
Biological characterization of bovine herpesvirus 1 recombinants possessing the vaccine glycoprotein E negative phenotype
Keywords: واکسن مارکر; Bovine herpesvirus 1; Recombination; Glycoprotein E; Marker vaccine
Candidate multi-peptide-vaccine against classical swine fever virus induced potent immunity with serological marker
Keywords: واکسن مارکر; Classical swine fever virus (CSFV); Multi-peptide-vaccine (MPV); Marker vaccine; Aluminum adjuvant
Prime-boost strategies combining DNA and inactivated vaccines confer high immunity and protection in cattle against bovine herpesvirus-1
Keywords: واکسن مارکر; Prime-boost; DNA; Marker vaccine; BoHV-1
A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge
Keywords: واکسن مارکر; CSFV; DNA immunization; T cell response; Marker vaccine